FDA Application
-
NDC Search Results on Active Ingredient: acetaminophen
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2039-92 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; CAFFEINE; ASPIRIN | 0067-2042-05 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; ASPIRIN; CAFFEINE | 0067-2002-02 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN | 0031-0100-08 | Haleon US Holdings LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
PHENYLEPHRINE HYDROCHLORIDE; ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE | 0067-6803-02 | Haleon US Holdings LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
IBUPROFEN; ACETAMINOPHEN | 0573-0145-18 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2001-14 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 0067-2035-80 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 0067-2021-24 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-8203-02 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 0067-2035-91 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 0067-2000-83 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE | 0031-8771-12 | Haleon US Holdings LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2001-07 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
DEXTROMETHORPHAN HYDROBROMIDE; ACETAMINOPHEN | 0067-0103-06 | Haleon US Holdings LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2039-83 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; CAFFEINE | 0067-8139-01 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-8203-04 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; CAFFEINE | 0067-8139-02 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN | 0135-0609-04 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; IBUPROFEN | 0573-0147-86 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 0067-2035-20 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2040-08 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
PHENYLEPHRINE HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE; ACETAMINOPHEN | 0067-8136-20 | Haleon US Holdings LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE | 0135-7021-03 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; CHLORPHENIRAMINE MALEATE | 0067-8161-01 | Haleon US Holdings LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
PHENYLEPHRINE HYDROCHLORIDE; ACETAMINOPHEN | 0135-0607-03 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2039-02 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
DEXTROMETHORPHAN HYDROBROMIDE; ACETAMINOPHEN | 0067-0100-06 | Haleon US Holdings LLC | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
DIPHENHYDRAMINE CITRATE; CAFFEINE; ACETAMINOPHEN; ASPIRIN | 0067-8147-01 | Haleon US Holdings LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
-